HOPE AND ACCEPTANCE AT THE END OF LIFE - IMPACT OF SPIRITUALITY ON PALLIATIVE CARE PATIENTS

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Trial locations and contacts

1 site in 1 country.

About this study

Conditions

Hope, Acceptance, Spirituality

Being tested

Approach to spirituality through hope and acceptance

Keywords

hope, acceptance, spirituality, end of life, palliative care

Medical subject headings

Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

• Approach to spirituality through hope and acceptanceOther

  This study is a prospective longitudinal research study. The sample consisted of two groups: the Intervention Group, which included patients from the community palliative care support team (ECSCP-BM), and the Control Group, with primary health care selected patients from the family health units Nautilus and Coimbra Centro (CSP), with serious illness, comorbidities, and a poor prognosis. The patients chosen from ECSCP-BM were made up only of new patients referred to the team without any prior home consultations. The first questionnaire application took place during the first visit, and the second one was administered fourteen days later. The Primary Health Care patients were selected by invitation, and the questionnaire was administered. It included sociodemographic data, clinical data, the Herth Hope Index and open questions.

  During the palliative care team's home visit, spirituality was addressed in in the clinical history through the assessment of hope and acceptance.

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Hope

   Participants answered questions on the Hope Scale. There were 9 questions with 4 possible answers. Each answer was scored from 1 to 4. The maximum score on the scale was 36.

   Measured: 5 months

2. Acceptance

   Participants answered three open-ended questions to assess their acceptance. These questions were asked to the control group and at the first assessment of the intervention group. At the second assessment of the intervention group, after 14 days, a fourth question was also asked, assessing the team's intervention during those 14 days.

   Measured: 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted11 Aug 2025
2. Study start1 Jan 2025
3. Primary completion31 May 2025
4. Study completion31 May 2025

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Other trials for HopeStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.